<?xml version="1.0" encoding="UTF-8"?>
<p>On Jan 19, 2020, case 1 (index patient) visited Wuhan (Hubei, China) for a meeting and then took a train from Wuhan on Jan 21 and arrived at Liaocheng (Shandong, China) on Jan 22 (
 <xref ref-type="fig" rid="F2">Figure 2</xref>). He had a fever of 37.8Â°C and a productive cough after 4 days (
 <xref ref-type="fig" rid="F2">Figure 2</xref> and 
 <xref rid="T1" ref-type="table">Table 1</xref>). On Jan 28, he was taken to Dong'e People's Hospital (Liaocheng, Shandong, China) by ambulance. After pre-screening and triage, he was admitted to the Infectious Disease Unit for isolation as a suspected case. His chest computed tomogram (CT) scans showed multiple mottling and ground-glass opacities in the bilateral lung (
 <xref ref-type="fig" rid="F3">Figure 3A</xref>), suggesting this patient has developed to pneumonia. SARS-CoV-2 nucleic acid tests (ORF1ab and N genes) of the nasopharyngeal swab samples were positive by qRT-PCR (BioGerm, Shanghai, China). According to the instruction, the kit covers 100% of known COVID-19 sequences and has no cross-reactivity with other pathogens, and the limit of detection of the kit is 1,000 copies/mL. His clinical classification was moderate. Remission was achieved after treatment with antiviral and traditional Chinese medicine.
</p>
